JF
Insider buying
Jon Faiz Kayyem bought $500K of Inhibrx Biosciences, Inc. (INBX) stock
Jon Faiz Kayyem, Dir of Inhibrx Biosciences, Inc. (INBX), bought 5,000 shares of INBX stock worth $500K, per an SEC Form 4 filed Sep 17, 2026.
It was an open-market purchase.
The trade happened on Sep 16, 2026, 1 day before it was made public.
INBX has moved +10.1% since the trade date, from $101.77 to $112.04 (Sep 21, 2026 close).
- Traded
- Sep 16, 2026
- Disclosed
- Sep 17, 2026
- Filing delay
- 1 day
- Price since
- +10.1%
- Role
- Dir
- Source
- SEC Form 4
More INBX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.